TABLE OF CONTENTSINTRODUCTION TABLE 2: Industry and Regulatory Samples TABLE 3A: Validated Tests Conducted by Sample Sources TABLE 3B: Non-Validated Tests Conducted by Sample Sources TABLE 4: Tests Conducted by Industry and Regulatory Agencies TABLE 4A: Validated Tests Conducted by Industry and Regulatory Agencies TABLE 4B: Non-Validated Tests Conducted by Industry and Regulatory Agens TABLE 5: Number of Tests Conducted by Family/Drug TABLE 5A: Validated Number of Tests Conducted by Family/Drug TABLE 5B: Non-Validated Number of Tests Conducted by Family/Drug TABLE 6: Number of Tests by Method by Family/Drug TABLE 6A: Comparison of Validated and Non-Validated Tests TABLE 7-1: Grade A Bulk Milk Pick-Up Tanker Testing TABLE 7-2: Grade A Pasteurized Fluid Milk and Milk Products Testing TABLE 7-3: Grade A Producer Testing TABLE 7-4: Grade A Other Testing (milk from silos, over-the-road tankeretc.) TABLE 7-5: Non-Grade A Bulk Milk Pick-Up Tanker Testing TABLE 7-6: Non-Grade A Pasteurized Fluid Milk and Milk Products Testing TABLE 7-7: Non-Grade A Producer Testing TABLE 7-8: Non-Grade A Other Testing (milk from silos, over-the-road tars, etc.) TABLE 8-1: Number of Tests by Method by Family/Drug for Grade A Bulk M Pick-Up Tanker Testing TABLE 8-2: Number of Tests by Method by Family/Drug for Grade A Pasteued Fluid Milk and Milk Products Testing TABLE 8-3: Number of Tests by Method by Family/Drug for Grade A Produceesting TABLE 8-4: Number of Tests by Method by Family/Drug for Grade A ther Testing (milk from silos, over-the-road tankers, etc.) TABLE 8-5: Number of Tests by Method by Family/Drug for Non-Grade A Bulilk Pick-Up Tanker Testing TABLE 8-6: Number of Tests by Method by Family/Drug for Non-Grade A Paurized Fluid Milk and Milk Products Testing TABLE 8-7: Number of Tests by Method by Family/Drug for Non-Grade A Producer Testing TABLE 8-8: Number of Tests by Method by Family/Drug for Non-Grade Aher Testing (milk from silos, over-the-road tankers, etc.) |
The National Milk Drug Residue Data Base is a voluntary industry reporting program. Mandatory reporting is required by State regulatory agencies under the National Conference on Interstate Milk Shipments (NCIMS). Data are reported on the extent of the national testing activities, the analytical methods used, the kind and extent of the animal drug residues identified, and the amount of contaminated milk, including whether it was disposed of properly for non-human use. The system includes all milk, Grade A and non-Grade A, commonly known as manufacturing grade. Grade A milk represents approximately 90% of the milk supply and is regulated through NCIMS by State regulatory agencies. Manufacturing grade milk is under the direction of the regulatory agencies in the States where it is produced and may be subject to the standards recommended by the United States Department of Agriculture (USDA). Data reported to the National Milk Drug Residue Data Base are for educational and analytical purposes and are not intended or suitable for regulatory follow-up.
The National Conference on Interstate Milk Shipments (NCIMS) is a voluntary organization directed and controlled by member States to promote the availability of a high quality milk supply. FDA and the NCIMS through their collaborative efforts have developed a cooperative, federal-state program (The Interstate Milk Shipper program) to ensure the sanitary quality of milk and milk products shipped interstate. During the 1991 meeting of the NCIMS, the Conference authorized a national program to compile the results of residue testing by industry and regulatory agencies.
Subsequently, FDA awarded a contract to develop a National Milk Drug Residue Data Base. The data base is operated by an independent third party, under contract to the FDA. The data base design was developed in consultation with a project advisory group with members from the FDA and a NCIMS committee representing dairy producers, dairy processors, USDA, State regulatory agencies, and academia. The data base was designed to promote maximum participation by the dairy industry to report on a voluntary basis all of their testing without compromising any confidential data. Information regarding individual firm's data is not submitted to the data base contractor. The data base includes results of the National Drug Residue Milk Monitoring Program (NDRMMP), a national drug residue in milk sampling program administered by FDA with the full cooperation by the States. Results from this program are reported to the data base by the States.
It is important to recognize that the samples and tests reported do not necessarily represent one hundred percent of the milk supply from every State. However, as State and industry participation in the data base increased, reporting of the number of samples and tests similarly increased. Continuing efforts are being made to ensure that there is uniform reporting among all the States and the industry and to ensure that the drugs and test methods reported are correct.
This report presents summary data on samples and tests conducted during the Fiscal Year 1999, October 1, 1998 to September 30, 1999. Fifty States and Puerto Rico submitted data for this report.
The Pasteurized Milk Ordinance (PMO) requires that all bulk milk tankers be sampled and analyzed for animal drug residues before the milk is processed. Any tanker found positive is rejected for human consumption.
During this period 4,232,665 samples were analyzed for animal drug residues. Of these samples 4,270 were positive for a residue. A total of 4,371,127 tests were reported on the samples for 15 different groups of families or individual drugs. Forty-nine testing methods were used to analyze the samples for residues. Details are presented in the tables in this report.
A SAMPLE is defined as representing a load or lot of milk sampled and analyzed, e.g. a bulk milk pickup tanker, producer, or over-the-road tanker, a silo, etc.
Table 1 shows the results of the samples tested by source.
Data are reported by four SOURCES OF SAMPLES:
A POSITIVE result, as used in this report, means that the sample was found to be positive for a drug residue by a test acceptable for taking regulatory action in a certified laboratory by a certified analyst or the milk was rejected on the basis of an initial test by the milk processors.
The DISPOSITION PER PMO column represents the amount of milk contained in the tank or lot found to be positive and disposed of in accordance with the PMO and/or applicable State regulations. The PMO governs the rules which State agencies use to implement their milk program.
TABLE 1 -- Sample Results October 1, 1998 to September 30, 1999 | ||||
Source of Sample | Total Samples | Number Positive | Percent Positive | Disposition per PMO (Pounds) |
Bulk Milk Pick-Up Tanker | 3,267,230 | 2,770 | 0.085% | 98,778,000 |
Pasteurized Fluid Milk and Milk Products | 55,478 | 2 | 0.004% | 163,000 |
Producer | 809,997 | 1,451 | 0.179% | 7,569,000 |
Other | 100,079 | 47 | 0.047% | 1,251,000 |
Total | 4,232,665 | 4,270 | * | 107,744,000 |
The asterisk (*) notes that a summary of the percent positive cannot be provided because there is not uniformity in terms of sampling in the four categories. For example, the PMO sets forth specific sampling requirements for beta-lactam testing as follows:
Table 2 presents these results in greater detail and shows the number of samples conducted by industry and by regulatory agencies. Industry samples are taken by processing facilities, receiving and transfer stations, and marketing groups or cooperatives. Industry samples may be conducted to meet the industry requirements of Appendix N of the PMO which sets forth testing requirements for animal drug residues or for quality control purposes. Regulatory samples are taken by State and local regulatory agencies.
TABLE 2 -- Industry and Regulatory Samples October 1, 1998 to September 30, 1999 | ||||||||
Source of Sample | Number of Industry Samples | Number of Positive Industry Samples | Number of Regulatory Samples | Number of Positive Regulatory Samples | Total Samples | Total Positive Samples | Total Percent Positive | Disposition Per PMO (Pounds) |
GRADE A | ||||||||
Bulk Milk Pick-Up Tanker | 2,959,503 | 2,477 | 21,737 | 15 | 2,981,240 | 2,492 | 0.084% | 90,278,000 |
Pasteurized Fluid Milk and Milk Products | 6,135 | 1 | 48,667 | 1 | 54,921 | 2 | 0.004% | 163,000 |
Producer | 585,459 | 1,089 | 162,831 | 229 | 748,290 | 1,318 | 0.176% | 7,547,000 |
Other | 85,660 | 28 | 6,599 | 12 | 92,259 | 40 | 0.043% | 1,020,000 |
NON-GRADE A | ||||||||
Bulk Milk Pick-Up Tanker1 | 285,674 | 278 | 316 | 0 | 285,990 | 278 | 0.097% | 8,500,000 |
Pasteurized Fluid Milk and Milk Products | 20 | 0 | 537 | 0 | 557 | 0 | 0% | 0 |
Producer | 60,543 | 132 | 1,045 | 1 | 61,588 | 133 | 0.216% | 5,000 |
Other | 6,795 | 7 | 1,025 | 0 | 7,820 | 7 | 0.090% | 231,000 |
TOTALS | 3,989,789 | 4,012 | 242,876 | 258 | 4,232,665 | 4,270 | 107,744,000 2 |
1 It is a common practice in some States, including two large milk production States, that bulk milk pick-up tankers pickup milk from Grade A and non-Grade A milk producers on the same truck. Then, these loads are delivered to non-Grade A processing facilities. Because of this commingling of the two grades of milk, all data related to these loads are reported under non-Grade A.
2 Note that this represents 0.0665% of the total milk supply of the annual production of 162 billion pounds.
* = See Table 1 for explanation
An objective of the National Milk Drug Residue Data Base is to record every test run on each sample analyzed. Since some samples are analyzed for more than one drug residue, the number of tests run is greater than the number of samples. To avoid duplicate reporting of samples, the number of samples analyzed is reported separately from the number of tests run in the data base.
Table 3 presents summary results of the number of tests which were conducted during October 1, 1998 to September 30, 1999. The term, validated test, as used in this report, is a test used for the screening of raw milk for drug residue which has been evaluated in accordance with Appendix N of the Pasteurized Milk Ordinance and found acceptable by FDA in accordance with the standards established for the evaluation of tests. In addition, FDA validated drug residue detection procedures for screening and quantitation of drug residues in milk may be used. Table 3A presents summary results using validated tests and Table 3B presents summary results using non-validated tests.
TABLE 3 -- Tests Conducted by Sample Sources October 1, 1998 to September 30, 1999 | |||
Source of Sample | Total Tests | Number of Tests Positive | Percent Positive |
Bulk Milk Pick-Up Tanker | 3,388,532 | 3,073 | 0.091 |
Pasteurized Fluid Milk and Milk Products | 59,091 | 11 | 0.019 |
Producer Samples | 815,133 | 1,641 | 0.201 |
Other | 108,371 | 47 | 0.043 |
Total | 4,371,127 | 4,772 | * |
* = See Table 1 for explanation.
TABLE 3A -- Validated Tests Conducted by Sample Sources October 1, 1998 to September 30, 1999 | |||
Source of Sample | Total Tests | Number of Tests Positive | Percent Positive |
Bulk Milk Pick-Up Tanker | 3,279,716 | 3,023 | 0.092 |
Pasteurized Fluid Milk and Milk Products | 58,301 | 11 | 0.019 |
Producer | 810,977 | 1,636 | 0.202 |
Other | 101,907 | 46 | 0.045 |
Total | 4,250,901 | 4,716 | * |
* = See Table 1 for explanation.
TABLE 3B -- Non-Validated Tests Conducted by Sample Sources October 1, 1998 to September 30, 1999 | |||
Source of Sample | Total Tests | Number of Tests Positive | Percent Positive |
Bulk Milk Pick-Up Tanker | 108,816 | 50 | 0.046 |
Pasteurized Fluid Milk and Milk Products | 790 | 0 | 0.000 |
Producer | 4,156 | 5 | 0.120 |
Other | 6,464 | 1 | 0.015 |
Total | 120,226 | 56 | * |
* = See Table 1 for explanation.
Table 4 presents additional details in terms of the tests conducted by industry and by regulatory agencies. Tables 4A and 4B present these data by validated and non-validated tests.
TABLE 4 -- Tests Conducted by Industry and Regulatory Agencies October 1, 1998 to September 30, 1999 | |||||||
Source of Sample | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Total Percent Positive |
GRADE A | |||||||
Bulk Milk Pick-Up Tanker1 | 3,076,175 | 2,776 | 24,992 | 18 | 3,101,167 | 2,794 | 0.090% |
Pasteurized Fluid Milk and Milk Products | 7,040 | 1 | 51,477 | 10 | 58,517 | 11 | 0.019% |
Producer | 590,487 | 1,222 | 162,907 | 282 | 753,394 | 1,504 | 0.200% |
Other | 92,453 | 28 | 7,728 | 12 | 100,181 | 40 | 0.040% |
NON-GRADE A | |||||||
Bulk Milk Pick-Up Tanker 1 | 286,913 | 279 | 452 | 0 | 287,365 | 279 | 0.097% |
Pasteurized Fluid Milk and Milk Products | 20 | 0 | 554 | 0 | 574 | 0 | 0.000% |
Producer | 60,694 | 136 | 1,045 | 1 | 61,739 | 137 | 0.222% |
Other | 6,820 | 7 | 1,370 | 0 | 8,190 | 7 | 0.085% |
TOTALS | 4,120,602 | 4,449 | 250,525 | 323 | 4,371,127 | 4,772 | * |
1 It is a common practice in some States, including two large milk production States, that bulk milk pick-up tankers pickup milk from Grade A and non-Grade A milk producers on the same truck. Then, these loads are delivered to non-Grade A processing facilities. Because of this commingling of the two grades of milk, all data related to these loads are reported under non-Grade A.
* = See Table 1 for explanation; Table 2 shows data on the disposition of milk in compliance with the PMO.
TABLE 4A -- Validated Tests Conducted by Industry and Regulatory Agencies October 1, 1998 to September 30, 1999 | |||||||
Source of Sample | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Total Percent Positive |
GRADE A | |||||||
Bulk Milk Pick-Up Tanker | 2,983,612 | 2,743 | 16,291 | 13 | 2,999,903 | 2,756 | 0.092% |
Pasteurized Fluid Milk and Milk Products | 6,992 | 1 | 50,735 | 10 | 57,727 | 11 | 0.019% |
Producer | 590,422 | 1,218 | 162,849 | 281 | 753,271 | 1,499 | 0.199% |
Other | 86,465 | 27 | 7,626 | 12 | 94,091 | 39 | 0.041% |
NON-GRADE A | |||||||
Bulk Milk Pick-Up Tanker | 279,384 | 267 | 429 | 0 | 279,813 | 267 | 0.095% |
Pasteurized Fluid Milk and Milk Products | 20 | 0 | 554 | 0 | 574 | 0 | 0.000% |
Producer | 56,661 | 136 | 1,045 | 1 | 57,706 | 137 | 0.237% |
Other | 6,467 | 7 | 1,349 | 0 | 7,816 | 7 | 0.090% |
TOTALS | 4,010,023 | 4,399 | 240,878 | 317 | 4,250,901 | 4,716 | * |
* = See Table 1 for explanation.
TABLE 4B -- Non-Validated Tests Conducted by Industry and Regulatory Agencies October 1, 1998 to September 30, 1999 | |||||||
Source of Sample | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Total Percent Positive |
GRADE A | |||||||
Bulk Milk Pick-Up Tanker | 92,563 | 33 | 8,701 | 5 | 101,264 | 38 | 0.038% |
Pasteurized Fluid Milk and Milk Products | 48 | 0 | 742 | 0 | 790 | 0 | 0.000% |
Producer | 65 | 4 | 58 | 1 | 123 | 5 | 4.065% |
Other | 5,988 | 1 | 102 | 0 | 6,090 | 1 | 0.016% |
NON-GRADE A | |||||||
Bulk Milk Pick-Up Tanker | 7,529 | 12 | 23 | 0 | 7,552 | 12 | 0.159% |
Pasteurized Fluid Milk and Milk Products | 0 | 0 | 0 | 0 | 0 | 0 | 0.000% |
Producer | 4,033 | 0 | 0 | 0 | 4,033 | 0 | 0.000% |
Other | 353 | 0 | 21 | 0 | 374 | 0 | 0.000% |
TOTALS | 110,579 | 50 | 9,647 | 6 | 120,226 | 56 | * |
1 It is a common practice in some States, including two large milk production States, that bulk milk pick-up tankers pickup milk from Grade A and non-Grade A milk producers on the same truck. Then, these loads are delivered to non-Grade A processing facilities. Because of this commingling of the two grades of milk, all data related to these loads are reported under non-Grade A.
* = See Table 1 for explanation; Table 2 shows data on the disposition of milk in compliance with the PMO.
Table 5 shows the number of tests conducted by family and by individual drug. Tables 5A and 5B present these data by validated and non-validated tests.
TABLE 5 -- Number of Tests Conducted by Family/Drug October 1, 1998 to September 30, 1999 | ||
Family/Drug | Total Tests | Total Positive |
AMINOGLYCOSIDES | 1,172 | 3 |
BETA-LACTAMS | 4,132,296 | 4,639 |
Ceftiofur | 6,846 | 0 |
Cloxacillin | 6,701 | 62 |
CHLORAMPHENICOL | 1,343 | 0 |
GENTAMICIN | 7,180 | 5 |
MACROLIDES | 978 | 0 |
NEOMYCIN | 5,265 | 7 |
NOVOBIOCIN | 501 | 0 |
SULFONAMIDES | 101,603 | 10 |
Sulfadimethoxine | 9,209 | 0 |
Sulfamethazine | 24,735 | 5 |
Sulfathiazole | 8,232 | 0 |
TETRACYCLINES | 64,946 | 41 |
TILMICOSIN | 120 | 0 |
TOTALS | 4,371,127 | 4,772 |
TABLE 5A -- Number of Validated Tests Conducted by Family/Drug October 1, 1998 to September 30, 1999 | ||
Family/Drug | Total Tests | Total Positive |
BETA-LACTAMS | 4,127,835 | 4,637 |
Ceftiofur | 6,846 | 0 |
Cloxacillin | 6,701 | 62 |
CHLORAMPHENICOL | 1,343 | 0 |
SULFONAMIDES | 86,250 | 10 |
TETRACYLINES | 21,806 | 7 |
TILMICOSIN | 120 | 0 |
TOTALS | 4,250,901 | 4,716 |
TABLE 5B -- Number of Non-Validated Tests Conducted by Family/Drug October 1, 1998 to September 30, 1999 | ||
Family/Drug | Total Tests | Total Positive |
AMINOGLYCOSIDES | 1,172 | 3 |
BETA-LACTAMS | 4,461 | 2 |
GENTAMICIN | 7,180 | 5 |
MACROLIDES | 978 | 0 |
NEOMYCIN | 5,265 | 7 |
NOVOBIOCIN | 501 | 0 |
SULFONAMIDES | 15,353 | 0 |
Sulfadimethoxine | 9,209 | 0 |
Sulfamethazine | 24,735 | 5 |
Sulfathiazole | 8,232 | 0 |
TETRACYCLINES | 43,140 | 34 |
TOTALS | 120,226 | 56 |
Table 6 presents details on the tests used. The data in this table are comparable to Table 5, but the data are arranged by tests within each family/drug. Therefore, the totals are the same in both tables. The tests with the largest use were Snap (Reader) - Beta-Lactams and Charm II Tablet Competitive - Beta-Lactams used to test over 1.217 million and 581 thousand samples respectively. Charm II Tablet Sequential was used to test over 513 thousand samples. Charm BSDA Tablet - Beta-Lactams was used to test over 460 thousand samples. Table 6A shows a comparison of tests conducted using validated and non-validated test methods for sulfonmides and tetracyclines.
TABLE 6 -- Number of Tests By Method by Family/Drug October 1, 1998 to September 30, 1999 | |||
Tests By Method by Family/Drug | Number of Tests | Number Positive | Percent Positive |
AMINOGLYCOSIDES | |||
Charm II Tablet Competitive ** | 1,060 | 3 | 0.283% |
Charm II Tablet Sequential ** | 112 | 0 | 0.000% |
BETA-LACTAMS | |||
Charm BSDA Tablet - Beta-Lactams | 460,935 | 1,047 | 0.227% |
Charm Farm - Beta-Lactams ** | 735 | 2 | 0.272% |
Charm I Liquid - Beta-Lactams | 2,346 | 1 | 0.043% |
Charm I/Cowside II Tablet - Beta-Lactams | 75,815 | 87 | 0.115% |
Charm II Liquid - Beta-Lactams | 817 | 0 | 0.0% |
Charm II Tablet Competitive | 581,346 | 427 | 0.073% |
Charm II Tablet Quantitative | 26,359 | 221 | 0.838% |
Charm II Tablet Sequential | 513,340 | 373 | 0.073% |
Charm II Tablet Transit - Beta-Lactams | 15,255 | 8 | 0.052% |
Charm SL Beta-Lactams | 7,480 | 3 | 0.040% |
Delvo-X-PRESS - Beta-Lactams | 26,296 | 36 | 0.137% |
Delvotest P 5 Pack - Beta-Lactams | 285,813 | 319 | 0.112% |
Delvotest P/Delvotest P Mini | 79,127 | 32 | 0.040% |
Delvotest SP/Delvotest SP Mini | 8,142 | 9 | 0.111% |
Difco BSDA - Beta-Lactams ** | 3,726 | 0 | 0.0% |
Lak Tek - Beta-Lactams | 354,623 | 449 | 0.127% |
Penzyme III Test - Beta-Lactams | 76,708 | 55 | 0.072% |
Penzyme Milk Test - Beta-Lactams | 43,528 | 20 | 0.046% |
Snap (Reader) - Beta-Lactams | 1,217,375 | 1,084 | 0.089% |
Snap (Visual) - Beta-Lactams | 352,368 | 466 | 0.132% |
CEFTIOFUR | |||
Lak Tek - Ceftiofur | 6,846 | 0 | 0.0% |
CLOXACILLIN | |||
Charm II Tablet Quantitative | 2,761 | 50 | 1.811% |
Charm II Test for Cloxacillin in Milk | 3,940 | 12 | 0.305% |
CHLORAMPHENICOL | |||
Charm II Tablet Competitive | 1,343 | 0 | 0.0% |
GENTAMICIN | |||
Charm II Tablet Competitive - Gentamicin ** | 607 | 2 | 0.329% |
Cite Probe Gentamicin ** | 1,323 | 1 | 0.076% |
ID Block - Gentamicin ** | 5,207 | 2 | 0.038% |
Lak Tek - Gentamicin ** | 43 | 0 | 0.0% |
MACROLIDES | |||
Charm II Tablet Competitive - Macrolides ** | 47 | 0 | 0.0% |
Charm II Tablet Sequential - Macrolides ** | 931 | 0 | 0.0% |
NEOMYCIN | |||
ID Block - Neomycin ** | 5,265 | 7 | 0.133% |
NOVOBIOCIN | 0.0% | ||
Charm II Tablet Competitive - Novobiocin | 501 | 0 | 0.0% |
SULFONAMIDES | |||
Agri-Screen for Sulfonamides ** | 25 | 0 | 0.0% |
Charm II Liquid - Sulfonamides ** | 125 | 0 | 0.0% |
Charm II Tablet Competitive | 86,250 | 10 | 0.012% |
Charm II Tablet Sequential ** | 15,203 | 0 | 0.0% |
SULFADIMETHOXINE | |||
Charm II Tablet Competitive | 872 | 0 | 0.0% |
Cite Sulfa Trio - Sulfadimethoxine ** | 8,337 | 0 | 0.0% |
SULFAMETHAZINE | |||
Cite Sulfa Trio - Sulfamethazine ** | 8,528 | 1 | 0.012% |
ID Block - Sulfamethazine ** | 12,813 | 4 | 0.031% |
Lak Tek - Sulfamethazine ** | 3,394 | 0 | 0.0% |
SULFATHIAZOLE | |||
Cite Sulfa Trio - Sulfathiazole ** | 8,232 | 0 | 0.0% |
TETRACYCLINES | |||
Charm II Tablet Competitive | 21,806 | 7 | 0.032% |
Lak Tek - Tetracyclines ** | 4,015 | 0 | 0.0% |
Snap - Tetracyclines ** | 39,125 | 34 | 0.087% |
TILMICOSIN | |||
HPLC - Tilmicosin | 120 | 0 | 0.0% |
TOTALS | 4,371,127 | 4,772 | * |
* = See Table 1 for explanation.
** Non-Validated Test Method
TABLE 6A -- Comparison of Validated and Non-Validated Tests for Sulfonamides and Tetracyclines October 1, 1998 to September 30, 1999 | |||
Tests By Method by Family/Drug | Number of Tests | Number Positive | Percent Positive |
VALIDATED FOR SULFONAMIDES | |||
Charm II Tablet Competitive | 86,250 | 10 | 0.012% |
SULFADIMETHOXINE | |||
Charm II Tablet Competitive | 872 | 0 | 0.0% |
NON-VALIDATED FOR SULFONAMIDES | |||
Agri-Screen for Sulfonamides | 25 | 0 | 0.0% |
Charm II Liquid - Sulfonamides | 125 | 0 | 0.0% |
Charm II Tablet Sequential | 15,203 | 0 | 0.0% |
SULFAMETHAZINE | |||
Cite Sulfa Trio - Sulfamethazine | 8,528 | 1 | 0.012% |
ID Block - Sulfamethazine | 12,813 | 4 | 0.031% |
Lak Tek - Sulfamethazine | 3,394 | 0 | 0.0% |
VALIDATED FOR TETRACYCLINES | |||
Charm II Tablet Competitive | 21,806 | 7 | 0.032% |
NON-VALIDATED FOR TETRACYCLINES | |||
Lak Tek - Tetracyclines | 4,015 | 0 | 0.0% |
Snap - Tetracyclines | 39,125 | 34 | 0.087% |
* = See Table 1 for explanation.
** Non-Validated Test Method
Tables 7-1 to 7-8 present additional details of the testing conducted. These tables show the testing by family and by individual drugs and present results in terms of Grade A and non- Grade A testing. Data on individual drugs listed in these tables, e.g., gentamicin, ceftiofur, etc., are not included in the total for the family, e.g., aminoglycosides, beta-lactams, etc.
TABLE 7-1 -- Grade A Bulk Milk Pick-Up Tanker Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
AMINOGLYCOSIDES | 423 | 0 | 108 | 3 | 531 | 3 |
BETA-LACTAMS | 2,874,573 | 2,682 | 15,009 | 13 | 2,889,582 | 2,695 |
Ceftiofur | 3,635 | 0 | 297 | 0 | 3,932 | 0 |
Cloxacillin | 6,306 | 44 | 48 | 0 | 6,354 | 4 |
CHLORAMPHENICOL | 737 | 0 | 105 | 0 | 842 | 0 |
GENTAMICIN | 6,199 | 3 | 96 | 1 | 6,295 | 4 |
MACROLIDES | 491 | 0 | 0 | 0 | 491 | 0 |
NEOMYCIN | 5,265 | 7 | 0 | 0 | 5,265 | 7 |
NOVOBIOCIN | 26 | 0 | 0 | 0 | 26 | 0 |
SULFONAMIDES | 94,024 | 10 | 577 | 0 | 94,601 | 10 |
Sulfadimethoxine | 5,564 | 0 | 2,180 | 0 | 7,744 | 0 |
Sulfamethazine | 21,017 | 5 | 2,113 | 0 | 23,130 | 5 |
Sulfathiazole | 4,770 | 0 | 2,113 | 0 | 6,883 | 0 |
TETRACYCLINES | 53,145 | 25 | 2,346 | 1 | 55,491 | 26 |
TOTALS | 3,076,175 | 2,776 | 24,992 | 18 | 3,101,167 | 2,794 |
TABLE 7-2 -- Grade A Pasteurized Fluid Milk and Milk Products Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
BETA-LACTAMS | 6,712 | 1 | 49,222 | 10 | 55,934 | 11 |
Ceftiofur | 0 | 0 | 1,502 | 0 | 1,502 | 0 |
SULFONAMIDES | 280 | 0 | 0 | 0 | 280 | 0 |
Sulfadimethoxine | 16 | 0 | 187 | 0 | 203 | 0 |
Sulfamethazine | 16 | 0 | 187 | 0 | 203 | 0 |
Sulfathiazole | 16 | 0 | 187 | 0 | 203 | 0 |
TETRACYCLINES | 0 | 0 | 192 | 0 | 192 | 0 |
TOTALS | 7,040 | 1 | 51,477 | 9 | 58,517 | 11 |
TABLE 7-3 -- Grade A Producer Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
AMINOGYLCOSIDES | 0 | 0 | 5 | 0 | 5 | 0 |
BETA-LACTAMS | 586,416 | 1,202 | 162,549 | 281 | 748,965 | 1,483 |
Ceftiofur | 18 | 0 | 193 | 0 | 211 | 0 |
Cloxacillin | 322 | 18 | 3 | 0 | 325 | 18 |
CHLORAMPHENICOL | 0 | 0 | 5 | 0 | 5 | 0 |
GENTAMICIN | 0 | 0 | 25 | 0 | 25 | 0 |
MACROLIDES | 9 | 0 | 3 | 0 | 12 | 0 |
SULFONAMIDES | 3,676 | 0 | 79 | 0 | 3,755 | 0 |
Sulfadimethoxine | 2 | 0 | 0 | 0 | 2 | 0 |
Sulfamethazine | 2 | 0 | 0 | 0 | 2 | 0 |
Sulfathiazole | 2 | 0 | 0 | 0 | 2 | 0 |
TETRACYCLINES | 40 | 2 | 45 | 1 | 85 | 3 |
TOTALS | 590,487 | 1,222 | 162,907 | 282 | 753,394 | 1,504 |
TABLE 7-4 -- Grade A Other Testing (milk from silos, over-the-road tankers, etc.) October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
AMINOGLYCOSIDES | 475 | 0 | 59 | 0 | 534 | 0 |
BETA-LACTAMS | 82,471 | 27 | 6,817 | 12 | 89,288 | 39 |
Ceftiofur | 608 | 0 | 360 | 0 | 968 | 0 |
Cloxacillin | 0 | 0 | 13 | 0 | 13 | 0 |
CHLORAMPHENICOL | 475 | 0 | 6 | 0 | 481 | 0 |
GENTAMICIN | 597 | 1 | 19 | 0 | 616 | 1 |
MACROLIDES | 475 | 0 | 0 | 0 | 475 | 0 |
NOVOBIOCIN | 475 | 0 | 0 | 0 | 475 | 0 |
SULFONAMIDES | 2,081 | 0 | 259 | 0 | 2,340 | 0 |
Sulfadimethoxine | 1,142 | 0 | 15 | 0 | 1,157 | 0 |
Sulfamethazine | 1,378 | 0 | 4 | 0 | 1,382 | 0 |
Sulfathiazole | 1,128 | 0 | 4 | 0 | 1,132 | 0 |
TETRACYCLINES | 1,148 | 0 | 172 | 0 | 1,320 | 0 |
TOTALS | 92,453 | 28 | 7,728 | 12 | 100,181 | 40 |
TABLE 7-5 -- Non-Grade A Bulk Milk Pick-Up Tanker Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
AMINOGLYCOSIDES | 102 | 0 | 0 | 0 | 102 | 0 |
BETA-LACTAMS | 278,524 | 267 | 320 | 0 | 278,844 | 267 |
Ceftiofur | 53 | 0 | 49 | 0 | 102 | 0 |
Cloxacillin | 0 | 0 | 1 | 0 | 1 | 0 |
CHLORAMPHENICOL | 0 | 0 | 15 | 0 | 15 | 0 |
GENTAMICIN | 235 | 0 | 9 | 0 | 244 | 0 |
SULFONAMIDES | 592 | 0 | 35 | 0 | 627 | 0 |
Sulfadimethoxine | 5 | 0 | 0 | 0 | 5 | 0 |
Sulfamethazine | 5 | 0 | 0 | 0 | 5 | 0 |
Sulfathiazole | 5 | 0 | 0 | 0 | 5 | 0 |
TETRACYCLINES | 7,272 | 12 | 23 | 0 | 7,295 | 12 |
TILMICOSIN | 120 | 0 | 0 | 0 | 120 | 0 |
TOTALS | 286,913 | 279 | 452 | 0 | 287,365 | 279 |
TABLE 7-6 -- Non-Grade A Pasteurized Fluid Milk and Milk Products Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
BETA-LACTAMS | 20 | 0 | 554 | 0 | 574 | 0 |
TOTALS | 20 | 0 | 554 | 0 | 574 | 0 |
TABLE 7-7 -- Non-Grade A Producer Testing October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
BETA-LACTAMS | 60,387 | 136 | 1,045 | 1 | 61,432 | 137 |
Sulfadimethoxine | 91 | 0 | 0 | 0 | 91 | 0 |
TETRACYCLINES | 216 | 0 | 0 | 0 | 216 | 0 |
TOTALS | 60,694 | 136 | 1,045 | 1 | 61,739 | 137 |
TABLE 7-8 -- Non-Grade A Other Testing (milk from silos, over-the-road tankers, etc.) October 1, 1998 to September 30, 1999 | ||||||
Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests |
BETA-LACTAMS | 6,467 | 7 | 1,210 | 0 | 7,677 | 7 |
Ceftiofur | 0 | 0 | 131 | 0 | 131 | 0 |
Cloxacillin | 0 | 0 | 8 | 0 | 8 | 0 |
SULFONAMIDES | ||||||
Sulfadimethoxine | 0 | 0 | 7 | 0 | 7 | 0 |
Sulfamethazine | 6 | 0 | 7 | 0 | 13 | 0 |
Sulfathiazole | 0 | 0 | 7 | 0 | 7 | 0 |
TETRACYCLINES | 347 | 0 | 0 | 0 | 347 | 0 |
TOTALS | 6,820 | 7 | 1,370 | 0 | 8,190 | 7 |
Tables 8-1 to 8-8 present details on the number of tests conducted by industry and by regulatory agencies. The data are arranged by test within each family/drug and present results in terms of sample type and Grade A and non-Grade A testing.
Table 8-1 -- Number of Tests By Method by Family/Drug Grade A Bulk Milk Pick-Up Tanker October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
AMINOGLYCOSIDES | |||||||
Charm II Tablet Competitive | 423 | 0 | 98 | 3 | 521 | 3 | 0.576% |
Charm II Tablet Sequential | 0 | 0 | 10 | 0 | 10 | 0 | 0.0% |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 182 | 6 | 3,870 | 0 | 4,052 | 6 | 0.148% |
Charm Farm - Beta-Lactams | 723 | 0 | 0 | 0 | 723 | 0 | 0.0% |
Charm I Liquid - Beta-Lactams | 2,324 | 1 | 0 | 0 | 2,324 | 1 | 0.043% |
Charm I/Cowside II Tablet - Beta-Lactams | 63,743 | 76 | 64 | 0 | 63,807 | 76 | 0.119% |
Charm II Liquid - Beta-Lactams | 450 | 0 | 0 | 0 | 450 | 0 | 0.0% |
Charm II Tablet Competitive | 528,796 | 380 | 377 | 0 | 529,173 | 380 | 0.072% |
Charm II Tablet Quantitative | 23,075 | 186 | 303 | 0 | 23,378 | 186 | 0.796% |
Charm II Tablet Sequential | 482,238 | 323 | 2,180 | 2 | 484,418 | 325 | 0.067% |
Charm II Tablet Transit - Beta-Lactams | 9,851 | 8 | 0 | 0 | 9,851 | 8 | 0.081% |
Charm SL Beta-Lactams | 7,156 | 3 | 0 | 0 | 7,156 | 3 | 0.042% |
Delvo-X-PRESS - Beta-Lactams | 22,249 | 33 | 0 | 0 | 22,249 | 33 | 0.148% |
Delvotest P 5 Pack - Beta-Lactams | 1,623 | 8 | 3,263 | 0 | 4,886 | 8 | 0.164% |
Delvotest P/Delvotest P Mini | 2,742 | 2 | 3,079 | 0 | 5,821 | 2 | 0.034% |
Delvotest SP/Delvotest SP Mini | 6,470 | 7 | 0 | 0 | 6,470 | 7 | 0.108% |
Lak Tek - Beta-Lactams | 309,268 | 360 | 309 | 10 | 309,577 | 370 | 0.120% |
Penzyme III Test - Beta-Lactams | 37,608 | 20 | 0 | 0 | 37,608 | 20 | 0.053% |
Penzyme Milk Test - Beta-Lactams | 19,997 | 9 | 1 | 0 | 19,998 | 9 | 0.045% |
Snap (Reader) - Beta-Lactams | 1,059,047 | 860 | 507 | 1 | 1,059,554 | 861 | 0.081% |
Snap (Visual) - Beta-Lactams | 297,031 | 400 | 1,056 | 0 | 298,087 | 400 | 0.134% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 3,635 | 0 | 297 | 0 | 3,932 | 0 | 0.0% |
CLOXACILLIN | |||||||
Charm II Tablet Quantitative | 2,496 | 37 | 14 | 0 | 2,510 | 37 | 1.474% |
Charm II Test for Cloxacillin in Milk | 3,810 | 7 | 34 | 0 | 3,844 | 7 | 0.182% |
CHLORAMPHENICOL | |||||||
Charm II Tablet Competitive | 737 | 0 | 105 | 0 | 842 | 0 | 0.0% |
GENTAMICIN | |||||||
Charm II Tablet Competitive - Gentamicin | 35 | 1 | 71 | 1 | 106 | 2 | 1.887% |
Cite Probe Gentamicin | 1,159 | 0 | 15 | 0 | 1,174 | 0 | 0.0% |
ID Block - Gentamicin | 4,972 | 2 | 0 | 0 | 4,972 | 2 | 0.040% |
Lak Tek - Gentamicin | 33 | 0 | 10 | 0 | 43 | 0 | 0.0% |
MACROLIDES | |||||||
Charm II Tablet Competitive - Macrolides | 45 | 0 | 0 | 0 | 45 | 0 | 0.0% |
Charm II Tablet Sequential - Macrolides | 446 | 0 | 0 | 0 | 446 | 0 | 0.0% |
NEOMYCIN | |||||||
ID Block - Neomycin | 5,265 | 7 | 0 | 0 | 5,265 | 7 | 0.133% |
NOVOBIOCIN | |||||||
Charm II Tablet Competitive - Novobiocin | 26 | 0 | 0 | 0 | 26 | 0 | 0.0% |
SULFONAMIDES | |||||||
Agri-Screen for Sulfonamides | 25 | 0 | 0 | 0 | 25 | 0 | 0.0% |
Charm II Liquid - Sulfonamides | 99 | 0 | 26 | 0 | 125 | 0 | 0.0% |
Charm II Tablet Competitive | 79,000 | 10 | 278 | 0 | 79,278 | 10 | 0.013% |
Charm II Tablet Sequential | 14,900 | 0 | 273 | 0 | 15,173 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Charm II Tablet Competitive | 794 | 0 | 67 | 0 | 861 | 0 | 0.0% |
Cite Sulfa Trio - Sulfadimethoxine | 4,770 | 0 | 2,113 | 0 | 6,883 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 4,810 | 1 | 2,113 | 0 | 6,923 | 1 | 0.014% |
ID Block - Sulfamethazine | 12,813 | 4 | 0 | 0 | 12,813 | 4 | 0.031% |
Lak Tek - Sulfamethazine | 3,394 | 0 | 0 | 0 | 3,394 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 4,770 | 0 | 2,113 | 0 | 6,883 | 0 | 0.0% |
TETRACYCLINES | |||||||
Charm II Tablet Competitive | 20,084 | 7 | 554 | 0 | 20,638 | 7 | 0.034% |
Lak Tek - Tetracyclines | 4,015 | 0 | 0 | 0 | 4,015 | 0 | 0.0% |
Snap - Tetracyclines | 29,046 | 18 | 1,792 | 1 | 30,838 | 19 | 0.062% |
TOTALS | 3,076,175 | 2,776 | 24,992 | 18 | 3,101,167 | 2,794 | 0.090% |
Table 8-2 -- Number of Tests By Method by Family/Drug Grade A Pasteurized Fluid Milk and Milk Products October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 3,820 | 0 | 23,802 | 1 | 27,622 | 1 | 0.004% |
Charm I Liquid - Beta-Lactams | 0 | 0 | 22 | 0 | 22 | 0 | 0.0% |
Charm I/Cowside II Tablet - Beta-Lactams | 0 | 0 | 19 | 0 | 19 | 0 | 0.0% |
Charm II Tablet Competitive | 648 | 0 | 659 | 1,307 | 0 | 0.0% | |
Charm II Tablet Quantitative | 439 | 0 | 0 | 0 | 439 | 0 | 0.0% |
Charm II Tablet Sequential | 254 | 1 | 3,430 | 0 | 3,684 | 1 | 0.027% |
Delvo-X-PRESS - Beta-Lactams | 0 | 0 | 77 | 0 | 77 | 0 | 0.0% |
Delvotest P 5 Pack - Beta-Lactams | 599 | 0 | 9,050 | 9 | 9,649 | 9 | 0.093% |
Delvotest P/Delvotest P Mini | 0 | 0 | 2,503 | 0 | 2,503 | 0 | 0.0% |
Delvotest SP/Delvotest SP Mini | 0 | 0 | 61 | 0 | 61 | 0 | 0.0% |
Lak Tek - Beta-Lactams | 0 | 0 | 1,548 | 0 | 1,548 | 0 | 0.0% |
Penzyme Milk Test - Beta-Lactams | 0 | 0 | 9 | 0 | 9 | 0 | 0.0% |
Snap (Reader) - Beta-Lactams | 259 | 0 | 229 | 0 | 488 | 0 | 0.0% |
Snap (Visual) - Beta-Lactams | 693 | 0 | 7,813 | 0 | 8,506 | 0 | 0.0% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 0 | 0 | 1,502 | 0 | 1,502 | 0 | 0.0% |
SULFONAMIDES | |||||||
Charm II Tablet Competitive | 280 | 0 | 0 | 0 | 280 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Cite Sulfa Trio - Sulfadimethoxine | 16 | 0 | 187 | 0 | 203 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 16 | 0 | 187 | 0 | 203 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 16 | 0 | 187 | 0 | 203 | 0 | 0.0% |
TETRACYCLINES | |||||||
Charm II Tablet Competitive | 0 | 0 | 11 | 0 | 11 | 0 | 0.0% |
Snap - Tetracyclines | 0 | 0 | 181 | 0 | 181 | 0 | 0.0% |
TOTALS | 7,040 | 1 | 51,477 | 10 | 58,517 | 11 | 0.0018% |
Table 8-3 -- Number of Tests By Method by Family/Drug Grade A Producer October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
AMINOGLYCOSIDES | |||||||
Charm II Tablet Competitive | 0 | 0 | 5 | 0 | 5 | 0 | 0.0% |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 293,887 | 795 | 77,376 | 131 | 371,263 | 926 | 0.249% |
Charm Farm - Beta-Lactams | 12 | 2 | 0 | 0 | 12 | 2 | 16.667% |
Charm I/Cowside II Tablet - Beta-Lactams | 863 | 1 | 20 | 0 | 883 | 1 | 0.113% |
Charm II Tablet Competitive | 10,663 | 24 | 329 | 6 | 10,992 | 30 | 0.273% |
Charm II Tablet Quantitative | 1,173 | 35 | 56 | 0 | 1,229 | 35 | 2.848% |
Charm II Tablet Sequential | 3,254 | 33 | 7,983 | 11 | 11,237 | 44 | 0.392% |
Charm SL Beta-Lactams | 6 | 0 | 0 | 0 | 6 | 0 | 0.0% |
Delvo-X-PRESS - Beta-Lactams | 3,956 | 3 | 0 | 0 | 3,956 | 3 | 0.076% |
Delvotest P 5 Pack - Beta-Lactams | 204,675 | 190 | 61,530 | 105 | 266,205 | 295 | 0.111% |
Delvotest P/Delvotest P Mini | 51,301 | 19 | 12,356 | 11 | 63,657 | 30 | 0.047% |
Delvotest SP/Delvotest SP Mini | 745 | 2 | 14 | 0 | 759 | 2 | 0.264% |
Lak Tek - Beta-Lactams | 2,975 | 28 | 1,673 | 9 | 4,648 | 37 | 0.796% |
Penzyme III Test - Beta-Lactams | 1,329 | 3 | 0 | 0 | 1,329 | 3 | 0.226% |
Penzyme Milk Test - Beta-Lactams | 1,197 | 0 | 0 | 0 | 1,197 | 0 | 0.0% |
Snap (Reader) - Beta-Lactams | 5,611 | 64 | 28 | 4 | 5,639 | 68 | 1.206% |
Snap (Visual) - Beta-Lactams | 4,769 | 3 | 1,184 | 4 | 5,953 | 7 | 0.118% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 18 | 0 | 193 | 0 | 211 | 0 | 0.0% |
CLOXACILLIN | |||||||
Charm II Tablet Quantitative | 231 | 13 | 2 | 0 | 233 | 13 | 5.579% |
Charm II Test for Cloxacillin in Milk | 91 | 5 | 1 | 0 | 92 | 5 | 5.435% |
CHLORAMPHENICOL | |||||||
Charm II Tablet Competitive | 0 | 0 | 5 | 0 | 5 | 0 | 0.0% |
GENTAMICIN | |||||||
Charm II Tablet Competitive - Gentamicin | 0 | 0 | 25 | 0 | 25 | 0 | 0.0% |
MACROLIDES | |||||||
Charm II Tablet Competitive - Macrolides | 0 | 0 | 2 | 0 | 2 | 0 | 0.0% |
Charm II Tablet Sequential - Macrolides | 9 | 0 | 1 | 0 | 10 | 0 | 0.0% |
SULFONAMIDES | |||||||
Charm II Tablet Competitive | 3,676 | 0 | 63 | 0 | 3,739 | 0 | 0.0% |
Charm II Tablet Sequential | 0 | 0 | 16 | 0 | 16 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Cite Sulfa Trio - Sulfadimethoxine | 2 | 0 | 0 | 0 | 2 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 2 | 0 | 0 | 0 | 2 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 2 | 0 | 0 | 0 | 2 | 0 | 0.0% |
TETRACYCLINES | |||||||
Charm II Tablet Competitive | 2 | 0 | 36 | 0 | 38 | 0 | 0.0% |
Snap - Tetracyclines | 38 | 2 | 9 | 1 | 47 | 3 | 6.383% |
TOTALS | 590,487 | 1,222 | 162,907 | 282 | 753,394 | 1,504 | 0.0199% |
Table 8-4 -- Number of Tests By Method by Family/Drug Grade A Other (milk from silos, over-the-road tankers, etc.) October 1, 1998 to September 1999 | |||||||
Tests By Method by Family /Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
AMINOGLYCOSIDES | |||||||
Charm II Tablet Competitive | 475 | 0 | 59 | 0 | 534 | 0 | 0.0% |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 3,356 | 0 | 4,302 | 1 | 7,658 | 1 | 0.013% |
Charm I/Cowside II Tablet - Beta-Lactams | 5,809 | 9 | 1 | 0 | 5,810 | 9 | 0.155% |
Charm II Tablet Competitive | 12,170 | 0 | 308 | 0 | 12,478 | 0 | 0.0% |
Charm II Tablet Quantitative | 1,117 | 0 | 104 | 0 | 1,221 | 0 | 0.0% |
Charm II Tablet Sequential | 9,766 | 1 | 546 | 0 | 10,312 | 1 | 0.010% |
Delvo-X-PRESS - Beta-Lactams | 0 | 0 | 14 | 0 | 14 | 0 | 0.0% |
Delvotest P 5 Pack - Beta-Lactams | 173 | 0 | 644 | 0 | 817 | 0 | 0.0% |
Delvotest P/Delvotest P Mini | 2,242 | 0 | 352 | 0 | 2,594 | 0 | 0.0% |
Delvotest SP/Delvotest SP Mini | 494 | 0 | 0 | 0 | 494 | 0 | 0.0% |
Lak Tek - Beta-Lactams | 15,083 | 6 | 408 | 0 | 15,491 | 6 | 0.039% |
Penzyme III Test - Beta-Lactams | 1,543 | 0 | 0 | 0 | 1,543 | 0 | 0.0% |
Snap (Reader) - Beta-Lactams | 29,280 | 11 | 42 | 0 | 29,322 | 11 | 0.038% |
Snap (Visual) - Beta-Lactams | 1,438 | 0 | 96 | 11 | 1,534 | 11 | 0.717% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 608 | 0 | 360 | 0 | 968 | 0 | 0.0% |
CLOXACILLIN | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
Charm II Tablet Quantitative | |||||||
Charm II Test for Cloxacillin in Milk | 0 | 0 | 4 | 0 | 4 | 0 | 0.0% |
CHLORAMPHENICOL | |||||||
Charm II Tablet Competitive | 475 | 0 | 6 | 0 | 481 | 0 | 0.0% |
GENTAMICIN | |||||||
Charm II Tablet Competitive - Gentamicin | 475 | 0 | 1 | 0 | 476 | 0 | 0.0% |
Cite Probe Gentamicin | 122 | 1 | 18 | 0 | 140 | 1 | 0.714% |
MACROLIDES | |||||||
Charm II Tablet Sequential - Macrolides | 475 | 0 | 0 | 0 | 475 | 0 | 0.0% |
NOVOBIOCIN | |||||||
Charm II Tablet Competitive - Novobiocin | 475 | 0 | 0 | 0 | 475 | 0 | 0.0% |
SULFONAMIDES | |||||||
Charm II Tablet Competitive | 2,081 | 0 | 259 | 0 | 2,340 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Charm II Tablet Competitive | 0 | 0 | 11 | 0 | 11 | 0 | 0.0% |
Cite Sulfa Trio - Sulfadimethoxine | 1,142 | 0 | 4 | 0 | 1,146 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 1,378 | 0 | 4 | 0 | 1,382 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 1,128 | 0 | 4 | 0 | 1,132 | 0 | 0.0% |
TETRACYCLINES | |||||||
Charm II Tablet Competitive | 830 | 0 | 171 | 0 | 1,001 | 0 | 0.0% |
Snap - Tetracyclines | 318 | 0 | 1 | 0 | 319 | 0 | 0.0% |
TOTALS | 92,453 | 28 | 7,728 | 12 | 100,181 | 40 | 0.040% |
Table 8-5 -- Number of Tests By Method by Family/Drug Non-Grade A Bulk Milk Pick-Up Tanker October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
AMINOGLYCOSIDES | |||||||
Charm II Tablet Sequential | 102 | 0 | 0 | 0 | 102 | 0 | 0.0% |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 2,858 | 1 | 159 | 0 | 3,017 | 1 | 0.033% |
Charm I/Cowside II Tablet - Beta-Lactams | 5,147 | 1 | 0 | 0 | 5,147 | 1 | 0.019% |
Charm II Liquid - Beta-Lactams | 367 | 0 | 0 | 0 | 367 | 0 | 0.0% |
Charm II Tablet Competitive | 27,200 | 17 | 0 | 0 | 27,200 | 17 | 0.063% |
Charm II Tablet Quantitative | 0 | 0 | 1 | 0 | 1 | 0 | 0.0% |
Charm II Tablet Sequential | 3,606 | 2 | 0 | 0 | 3,606 | 2 | 0.055% |
Charm II Tablet Transit - Beta-Lactams | 5,404 | 0 | 0 | 0 | 5,404 | 0 | 0.0% |
Charm SL Beta-Lactams | 318 | 0 | 0 | 0 | 318 | 0 | 0.0% |
Delvotest P 5 Pack - Beta-Lactams | 0 | 0 | 26 | 0 | 26 | 0 | 0.0% |
Delvotest P/Delvotest P Mini | 429 | 0 | 3 | 0 | 432 | 0 | 0.0% |
Delvotest SP/Delvotest SP Mini | 131 | 0 | 0 | 0 | 131 | 0 | 0.0% |
Lak Tek - Beta-Lactams | 22,620 | 36 | 49 | 0 | 22,669 | 36 | 0.159% |
Penzyme III Test - Beta-Lactams | 35,867 | 32 | 0 | 0 | 35,867 | 32 | 0.089% |
Penzyme Milk Test - Beta-Lactams | 22,147 | 11 | 62 | 0 | 22,209 | 11 | 0.050% |
Snap (Reader) - Beta-Lactams | 117,755 | 123 | 13 | 0 | 117,7681 | 123 | 0.104% |
Snap (Visual) - Beta-Lactams | 34,675 | 44 | 7 | 0 | 34,682 | 44 | 0.127% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 53 | 0 | 49 | 0 | 102 | 0 | 0.0% |
CLOXACILLIN | |||||||
Charm II Tablet Quantitative | 0 | 0 | 1 | 0 | 1 | 0 | 0.0% |
CHLORAMPHENICOL | |||||||
Charm II Tablet Competitive | 0 | 0 | 15 | 0 | 15 | 0 | 0.0% |
GENTAMICIN | |||||||
Cite Probe Gentamicin | 0 | 0 | 9 | 0 | 9 | 0 | 0.0% |
ID Block - Gentamicin | 235 | 0 | 0 | 0 | 235 | 0 | 0.0% |
SULFONAMIDES | |||||||
Charm II Tablet Competitive | 592 | 0 | 21 | 0 | 613 | 0 | 0.0% |
Charm II Tablet Sequential | 0 | 0 | 14 | 0 | 14 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Cite Sulfa Trio - Sulfadimethoxine | 5 | 0 | 0 | 0 | 5 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 5 | 0 | 0 | 0 | 5 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 5 | 0 | 0 | 0 | 5 | 0 | 0.0% |
TETRACYCLINES | |||||||
Charm II Tablet Competitive | 95 | 0 | 23 | 0 | 118 | 0 | 0.0% |
Snap - Tetracyclines | 7,177 | 12 | 0 | 0 | 7,177 | 12 | 0.167% |
TILMICOSIN | |||||||
HPLC - Tilmicosin | 120 | 0 | 0 | 0 | 120 | 0 | 0.0% |
TOTALS | 286,913 | 279 | 452 | 0 | 287,365 | 279 | 0.0970% |
Table 8-6 -- Number of Tests By Method by Family/Drug Non-Grade A Pasteurized Fluid Milk and Milk Products October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 20 | 0 | 308 | 0 | 328 | 0 | 0.0% |
Charm II Tablet Competitive | 0 | 0 | 25 | 0 | 25 | 0 | 0.0% |
Delvotest P 5 Pack - Beta-Lactams | 0 | 0 | 146 | 0 | 146 | 0 | 0.0% |
Delvotest P/Delvotest P Mini | 0 | 0 | 75 | 0 | 75 | 0 | 0.0% |
TOTALS | 20 | 0 | 554 | 0 | 574 | 0 | 0.0% |
Table 8-7 -- Number of Tests By Method by Family/Drug Non-Grade A Producer October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 45,661 | 112 | 814 | 0 | 46,475 | 112 | 0.241% |
Delvotest P 5 Pack - Beta-Lactams | 3,818 | 7 | 0 | 0 | 3,818 | 7 | 0.183% |
Delvotest P/Delvotest P Mini | 3,663 | 0 | 201 | 0 | 3,864 | 0 | 0.0% |
Delvotest SP/Delvotest SP Mini | 209 | 0 | 0 | 0 | 209 | 0 | 0.0% |
Difco BSDA - Beta-Lactams | 3,726 | 0 | 0 | 0 | 3,726 | 0 | 0.0% |
Penzyme III Test - Beta-Lactams | 190 | 0 | 0 | 0 | 190 | 0 | 0.0% |
Snap (Reader) - Beta-Lactams | 119 | 14 | 0 | 0 | 119 | 14 | 11.765% |
Snap (Visual) - Beta-Lactams | 3,001 | 3 | 30 | 1 | 3,031 | 4 | 0.132% |
SULFADIMETHOXINE | |||||||
Cite Sulfa Trio - Sulfadimethoxine | 91 | 0 | 0 | 0 | 91 | 0 | 0.0% |
TETRACYCLINES | |||||||
Snap - Tetracyclines | 216 | 0 | 0 | 0 | 216 | 0 | 0.0% |
TOTALS | 60,694 | 136 | 1,045 | 1 | 61,739 | 137 | 0.222% |
Table 8-8 -- Number of Tests By Method by Family/Drug Non-Grade A Other (milk from silos, over-the-road tankers, etc.) October 1, 1998 to September 1999 | |||||||
Tests By Method by Family/Drug | Number of Industry Tests | Number of Positive Industry Tests | Number of Regulatory Tests | Number of Positive Regulatory Tests | Total Tests | Total Positive Tests | Percent Positive |
BETA-LACTAMS | |||||||
Charm BSDA Tablet - Beta-Lactams | 16 | 0 | 504 | 0 | 520 | 0 | 0.0% |
Charm I/Cowside II Tablet - Beta-Lactams | 149 | 0 | 0 | 0 | 149 | 0 | 0.0% |
Charm II Tablet Competitive | 171 | 0 | 0 | 0 | 171 | 0 | 0.0% |
Charm II Tablet Quantitative | 0 | 0 | 91 | 0 | 91 | 0 | 0.0% |
Charm II Tablet Sequential | 0 | 0 | 83 | 0 | 83 | 0 | 0.0% |
Delvotest P 5 Pack - Beta-Lactams | 0 | 0 | 266 | 0 | 266 | 0 | 0.0% |
Delvotest P/Delvotest P Mini | 56 | 0 | 125 | 0 | 181 | 0 | 0.0% |
Delvotest SP/Delvotest SP Mini | 18 | 0 | 0 | 0 | 18 | 0 | 0.0% |
Lak Tek - Beta-Lactams | 558 | 0 | 132 | 0 | 690 | 0 | 0.0% |
Penzyme III Test - Beta-Lactams | 171 | 0 | 0 | 0 | 171 | 0 | 0.0% |
Penzyme Milk Test - Beta-Lactams | 115 | 0 | 0 | 0 | 115 | 0 | 0.0% |
Snap (Reader) - Beta-Lactams | 4,638 | 7 | 9 | 0 | 4,647 | 7 | 0.151% |
Snap (Visual) - Beta-Lactams | 575 | 0 | 0 | 0 | 575 | 0 | 0.0% |
CEFTIOFUR | |||||||
Lak Tek - Ceftiofur | 0 | 0 | 131 | 0 | 131 | 0 | 0.0% |
CLOXACILLIN | |||||||
Charm II Tablet Quantitative | 0 | 0 | 8 | 0 | 8 | 0 | 0.0% |
SULFADIMETHOXINE | |||||||
Cite Sulfa Trio - Sulfadimethoxine | 0 | 0 | 7 | 0 | 7 | 0 | 0.0% |
SULFAMETHAZINE | |||||||
Cite Sulfa Trio - Sulfamethazine | 6 | 0 | 7 | 0 | 13 | 0 | 0.0% |
SULFATHIAZOLE | |||||||
Cite Sulfa Trio - Sulfathiazole | 0 | 0 | 7 | 0 | 7 | 0 | 0.0% |
TETRACYCLINES | |||||||
Snap - Tetracyclines | 347 | 0 | 0 | 0 | 347 | 0 | 0.0% |
TOTALS | 6,820 | 7 | 1,370 | 0 | 8,190 | 7 | 0.085% |
To request the complete National Milk Drug Residue Data Base Fiscal Year 1999 Annual Report, please contact Ginger Levin, Project Director, at: GXL@CFSAN.FDA.GOV